Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Multi-marker longitudinal algorithms incorporating HE4 and CA125 in ovarian cancer screening of postmenopausal women

Gentry-Maharaj A., Blyuss O., Ryan A., Burnell M., Karpinskyj C., Gunu R., Kalsi J. K., Dawnay A., Marino I. P., Manchanda R., Lu K., Yang W. -., Timms J. F., Parmar M., Skates S. J., Bast R. C. J., Jacobs I. J., Zaikin A. A., Menon U.
Cancers
Vol.12, Issue7, Num.1931
Опубликовано: 2020
Тип ресурса: Статья

DOI:10.3390/cancers12071931

Аннотация:
Longitudinal CA125 algorithms are the current basis of ovarian cancer screening. We report on longitudinal algorithms incorporating multiple markers. In the multimodal arm of United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), 50,640 postmenopausal women underwent annual screening using a serum CA125 longitudinal algorithm. Women (cases) with invasive tubo-ovarian cancer (WHO 2014) following outcome review with stored annual serum samples donated in the 5 years preceding diagnosis were matched 1:1 to controls (no invasive tubo-ovarian cancer) in terms of the number of annual samples and age at randomisation. Blinded samples were assayed for serum human epididymis protein 4 (HE4), CA72-4 and anti-TP53 autoantibodies. Multimarker method of mean trends (MMT) longitudinal algorithms were developed using the assay results and trial CA125 values on the training set and evaluated in the blinded validation set. The study set comprised of 1363 (2–5 per woman) serial sample
Ключевые слова:
CA125; HE4; MMT; Ovarian cancer; Postmenopausal women; Screening; UKCTOCS
CA 125 antigen; CA 72-4 antigen; protein antibody; protein p53 autoantibody; unclassified drug; WAP four-disulfide core domain protein 2; adult; algorithm; antigen detection; Article; blood sampling; cancer screening; case control study; controlled study; diagnostic value; female; human; longitudinal study; major clinical study; ovary cancer; population research; postmenopause; protein analysis; protein blood level; sensitivity analysis; tuboovarian cancer; tumor invasion; United Kingdom; uterine tube tumor; validation process
Язык текста: Английский
ISSN: 2072-6694
Gentry-Maharaj A.
Blyuss O. Oleg 1985-
Ryan A.
Burnell M.
Karpinskyj C.
Gunu R.
Kalsi J. K.
Dawnay A.
Marino I. P.
Manchanda R.
Lu K.
Yang W. -. W.-L.
Timms J. F.
Parmar M.
Skates S. J.
Bast R. C. J. R.C. Jr.
Jacobs I. J.
Zaikin A. A. Aleksej Anatolyevich 1973-
Menon U.
Гентрy-Махарай А.
Блюсс О. Олег 1985-
Рян А.
Бурнелл М.
Карпинскyй C.
Гуну Р.
Калси Й. К.
Даwнай А.
Марино И. П.
Манчанда Р.
Лу К.
Янг W. -. W.-Л.
Тиммс Й. Ф.
Пармар М.
Скатес С. Й.
Баст Р. C. Й. Р.C. Йр.
Йаcобс И. Й.
Заикин А. А. Алексей Анатольевич 1973-
Менон У.
Multi-marker longitudinal algorithms incorporating HE4 and CA125 in ovarian cancer screening of postmenopausal women
Текст визуальный непосредственный
Cancers
Vol.12, Issue7 Num.1931
2020
Статья
CA125 HE4 MMT Ovarian cancer Postmenopausal women Screening UKCTOCS
CA 125 antigen CA 72-4 antigen protein antibody protein p53 autoantibody unclassified drug WAP four-disulfide core domain protein 2 adult algorithm antigen detection Article blood sampling cancer screening case control study controlled study diagnostic value female human longitudinal study major clinical study ovary cancer population research postmenopause protein analysis protein blood level sensitivity analysis tuboovarian cancer tumor invasion United Kingdom uterine tube tumor validation process
Longitudinal CA125 algorithms are the current basis of ovarian cancer screening. We report on longitudinal algorithms incorporating multiple markers. In the multimodal arm of United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), 50,640 postmenopausal women underwent annual screening using a serum CA125 longitudinal algorithm. Women (cases) with invasive tubo-ovarian cancer (WHO 2014) following outcome review with stored annual serum samples donated in the 5 years preceding diagnosis were matched 1:1 to controls (no invasive tubo-ovarian cancer) in terms of the number of annual samples and age at randomisation. Blinded samples were assayed for serum human epididymis protein 4 (HE4), CA72-4 and anti-TP53 autoantibodies. Multimarker method of mean trends (MMT) longitudinal algorithms were developed using the assay results and trial CA125 values on the training set and evaluated in the blinded validation set. The study set comprised of 1363 (2–5 per woman) serial sample